News

Dr Chiswell has been involved with Nabriva since its foundation, having served as chairman of the supervisory board for the past three years. He is currently chairman of

Topiramate tablets are indicated as an initial monotherapy in patients 10 years old or older with partial onset or primary generalized tonic-clonic seizures. Topiramate tablets are also indicated

Takeda said that it conducted the Phase III trial of Takepron for the treatment of Japanese patients who take low-dose aspirin in long period and submitted an application

Thomas, McNerney & Partners led the round along with a substantial investment from Split Rock Partners and insider investments from Prism Ventures, Tullis-Dickerson and Vector Group. With this

The marketing authorization application (MAA) for Cleviprex was submitted via the decentralized procedure, with the UK acting as the reference member state. Concerned member states participating in the

Co-investing in the Series A funding are Latterell Venture Partners of San Francisco, California, VantagePoint Venture Partners of San Bruno, California and Adams Street Partners of Chicago, Illinois.

The primary objective of the company’s Phase I trial with ARQ 621 is to determine its safety, tolerability and recommended Phase II dose. Patients with metastatic solid tumors

Brian Webster, president of Physio-Control, said: “With the Lifepak 15 monitor/defibrillator, Physio-Control is delivering on its commitment to provide innovative, reliable and durable equipment to emergency personnel so

For a period of up to five years, the Sanofi-Aventis regenerative medicine program (SARP) will sponsor institute-wide discovery grants in promising research areas that address the organizations’ mutual